Pacira BioSciences, Inc.
PCRX
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
14 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$22.05
Price+4.50%
$0.95
1Y
Price
Market Cap
$1.003b
Small
Price/Earnings 3y Avg5y Avg
46.9x
Premium
Premium
Financials Overview
Key metrics over the past few years+16.2%
EBITDA Margin-2.7%
Net Profit Margin+5.1%
Free Cash Flow MarginRevenue
$705.848m
+0.7%
1y CAGR+1.9%
3y CAGR+7.2%
5y CAGREarnings
-$127.460m
-28.0%
1y CAGR-67.2%
3y CAGR-65.9%
5y CAGREPS
-$2.78
-29.3%
1y CAGR-85.5%
3y CAGR-79.9%
5y CAGRBook Value
$757.767m
$1.537b
Assets$779.495m
Liabilities$631.403m
DebtDebt to Assets
41.1%
-1,387.7x
Debt to EBITDAFree Cash Flow
$117.068m
-34.5%
1y CAGR+4.9%
3y CAGR+14.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company